Different expression of glucose transporters in the progression of intrahepatic cholangiocarcinoma

作者: Yuichiro Kubo , Shinichi Aishima , Yuki Tanaka , Koji Shindo , Yusuke Mizuuchi

DOI: 10.1016/J.HUMPATH.2014.03.008

关键词:

摘要: Glucose transporter (GLUT)-1 is expressed in malignant tumors and correlated with poor outcome several cancers. Biliary intraepithelial neoplasia (BilIN) considered to be a precursor or noninvasive lesion of invasive cholangiocarcinoma. We examined GLUT-1 GLUT-2 expression 149 intrahepatic cholangiocarcinomas 39 BilINs immunohistochemically evaluated their correlation clinicopathological findings patient Furthermore, we the role on migration invasion cholangiocarcinoma cells using siRNA. In cholangiocarcinoma, was frequently observed near necrotic areas, whereas tended adenocarcinoma large bile ducts. Compared GLUT-1-negative group, GLUT-1-positive group showed significantly larger tumor size (P = .0031), differentiation < .0001), frequent lymphatic .0031) lymph node metastasis high HIF-1α .0297). good .0015), perihilar location perineural .0049), .0248). The patients disease related survival .0001). numbers migrating invading were decreased siRNA transfectants cells. Although, all grades BilINs, only high-grade BilINs. Our results suggest that correlates aggressive behavior prognosis, might therapeutic target may associated cholangiocarcinogenesis duct helpful marker for detecting BilIN lesions atypical

参考文章(30)
Volker Fendrich, Ralph Schneider, Anirban Maitra, Ilse D. Jacobsen, Thomas Opfermann, Detlef K. Bartsch, Detection of Precursor Lesions of Pancreatic Adenocarcinoma in PET-CT in a Genetically Engineered Mouse Model of Pancreatic Cancer Neoplasia. ,vol. 13, pp. 180- 186 ,(2011) , 10.1593/NEO.10956
Yasunori Sato, Kenichi Harada, Motoko Sasaki, Yasuni Nakanuma, Clinicopathological significance of S100 protein expression in cholangiocarcinoma Journal of Gastroenterology and Hepatology. ,vol. 28, pp. 1422- 1429 ,(2013) , 10.1111/JGH.12247
Ian F. Robey, Renu M. Stephen, Kathy S. Brown, Brenda K. Baggett, Robert A. Gatenby, Robert J. Gillies, Regulation of the Warburg Effect in Early-Passage Breast Cancer Cells Neoplasia. ,vol. 10, pp. 745- 756 ,(2008) , 10.1593/NEO.07724
Mamoun Younes, Richard W. Brown, Mark Stephenson, Margaret Gondo, Philip T. Cagle, Overexpression of glut1 and glut3 in stage I nonsmall cell lung carcinoma is Associated with poor survival Cancer. ,vol. 80, pp. 1046- 1051 ,(1997) , 10.1002/(SICI)1097-0142(19970915)80:6<1046::AID-CNCR6>3.0.CO;2-7
Ji-Youn Sung, Gou Young Kim, Sung-Jig Lim, Yong-Koo Park, Youn Wha Kim, Expression of the GLUT1 glucose transporter and p53 in carcinomas of the pancreatobiliary tract. Pathology Research and Practice. ,vol. 206, pp. 24- 29 ,(2010) , 10.1016/J.PRP.2009.07.018
Thomas Amann, Claus Hellerbrand, GLUT1 as a therapeutic target in hepatocellular carcinoma Expert Opinion on Therapeutic Targets. ,vol. 13, pp. 1411- 1427 ,(2009) , 10.1517/14728220903307509
Tetsuo Kawamura, Takashi Kusakabe, Takashi Sugino, Kazuo Watanabe, Takeaki Fukuda, Atsushi Nashimoto, Keiichi Honma, Toshimitsu Suzuki, Expression of glucose transporter-1 in human gastric carcinoma: association with tumor aggressiveness, metastasis, and patient survival. Cancer. ,vol. 92, pp. 634- 641 ,(2001) , 10.1002/1097-0142(20010801)92:3<634::AID-CNCR1364>3.0.CO;2-X
Masanori Yasuda, Masaki Miyazawa, Mariko Fujita, Hiroshi Kajiwara, Tetsuji Iida, Takeshi Hirasawa, Toshinari Muramatsu, Masaru Murakami, Mikio Mikami, Kaoru Saitoh, Michio Shimizu, Susumu Takekoshi, R. Osamura, Expression of hypoxia inducible factor-1alpha (HIF-1alpha) and glucose transporter-1 (GLUT-1) in ovarian adenocarcinomas: difference in hypoxic status depending on histological character. Oncology Reports. ,vol. 19, pp. 111- 116 ,(2008) , 10.3892/OR.19.1.111